Premium
The use of Depot neuroleptics in the elderly: A survey
Author(s) -
Thacker Simon
Publication year - 1996
Publication title -
international journal of geriatric psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.28
H-Index - 129
eISSN - 1099-1166
pISSN - 0885-6230
DOI - 10.1002/(sici)1099-1166(199605)11:5<423::aid-gps318>3.0.co;2-9
Subject(s) - depot , schizophrenia (object oriented programming) , psychiatry , extrapyramidal symptoms , chlorpromazine , medicine , geriatric psychiatry , psychology , pediatrics , antipsychotic , archaeology , history
A survey of psychiatric services across a city revealed 98 elderly patients who were receiving depot neuroleptics. Most had a diagnosis of schizophrenia, affective illness or paraphrenia and the majority received ‘depot’ as their only psychotropic medication. Extrapyramidal side‐effects as judged by psychiatric nurse key workers were significantly associated with high total neuroleptic dose (100 mg ‘chlorpromazine equivalent’ or more). Those with a diagnosis of paraphrenia were maintained on a lower median dose of ‘depot’ than their schizophrenic of affectively ill counterparts. Large differences in practice, not readily explained by case mix, but perhaps understandable in view of large variations in nursing workload, were observed.